EXHIBITOR MANUAL
DOWNLOAD THE ELRIG RESEARCH & INNOVATION 2023 EXHIBITOR MANUAL HERE
RESEARCH & INNOVATION 2023
Exhibitor Information
March 29-30
Hinxton Hall Conference Centre, Cambridge
PARKING
Parking is limited at Hinxton Hall Conference Centre. Those spaces made available upon registration are now fully booked. We have reserved one space for each exhibitor team. Please provide a registration plate number so ELRIG can provide to security.
COMPLIMENTARY COACHES
ELRIG are running complimentary coaches from Cambridge Train Station and Trumpington Park & Ride.If you would like to book a place on any of the coaches, please complete this booking form. Coach Booking Form
The Coach Departure times are:
March 29th
Outward
Cambridge Train Station 8:00
Trumpington Park & Ride 8:30
Return
Hinxton Conference centre 18:30
March 30th
Outward
Cambridge Train Station 8:00
Trumpington Park & Ride 8:30
Return
Hinxton Conference centre 17:00
If you prefer to pre-book a taxi one local company is Panther Taxis
#ELRIG
#RI2023
#RESEARCHINNOVATION2023
POSTER ABSTRACTS SUBMISSION.
All Exhibitors have one poster included in their package.
To submit an abstract, first you must Register Once completed you will be able to “Turn on Abstract Submissions” From here you can manage your abstracts.
There will be both a physical and digital poster. The physical poster should be A0 Portrait and there will be a board reserved for you in the Exhibition Room. The digital poster requires a PDF (Max 5mg) to be added to your poster at registration.
If you have already registered, you can login to your account here and “Turn on Abstract Submissions”
FLOORPLAN
The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2023 R&I meeting will focus on cutting edge innovation, comprising the following four main sessions.
- Synthetic biology: genetically programmed healthcare
-
- Synthetic biology is enabling drug development by improving the ability of scientists to design and engineer biological systems for specific purposes. These approaches can potentially lead to faster, more efficient, and more cost-effective, sustainable drug development. Furthermore, programmable gene circuits can provide novel functionality and control to therapeutic systems, thereby creating entirely new classes of cell and gene therapies.”
- Session Chairs: Ron Weiss (Massachusetts Institute of Technology), Simon Todd (AstraZeneca)
-
-
-
-
-
- Ultra-rare disease drug discovery and personalized therapies
-
- With improved (genetic) diagnosis and federated analytics for finding patients, we have come to realize that rare diseases are not so rare after all. Recent developments in drug development, including gene therapy and oligonucleotide therapy approvals are also opening up avenues for personalized or n=1 drugs. Clinical development is furthermore adapting to use biomarkers, single patient experimental medicine and decentralised clinical trials.
- Session Chairs: David Fischer (Charles River) & Joanne Hackett (IQVIA)
-
- Ultra-rare disease drug discovery and personalized therapies
-
-
-
- Age-Old Challenges, Modern Solutions: The Role of Geroscience In Addressing Age-Related Diseases
-
- Lifespan is increasing but healthy life expectancy is not keeping pace – we are living longer but not healthier. Geroscience aims to treat age-related diseases by addressing core ageing processes; novel drug discovery approaches have the potential to help deliver this objective.
- Session Chairs: Janet Lord (University of Birmingham), Lynne Cox (Oxford)
-
- The Rise of AI Driven Drug Discovery
-
- We are seeing a revolution in the application of AI to improve decision making in drug discovery. This session will focus on presenting and evaluating emerging technologies and innovations in AI which promise to drive drug discovery research in the future.
- Session Chairs: Garry Pairaudeau (Exscientia) & Kathryn Giblin (AstraZeneca)
-
CONFERENCE VENUE:
Hinxton Hall Conference Centre,
Wellcome Genome Campus,
Cambridge,
CB10 1SA
Our App
ALL OUR EVENT INFORMATION IN
THE PALM OF YOUR HAND
If you plan to attend an ELRIG event download the free ELRIG app and access all our conference information and lecture schedules and more straight from your phone or pad..